查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1776195

经颅都卜勒超音波的全球市场:洞察，竞争情形，市场预测:2032年

Transcranial Doppler - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计在2025年至2032年的预测期内，经颅多普勒市场将以5.89%的复合年增长率成长。创伤性脑损伤 (TBI) 的增加、中风和脑血管痉挛等神经系统疾病盛行率的上升以及运动相关损伤的急剧增加，显着推动了全球对经颅多普勒设备的需求。这些疾病需要持续、即时监测脑血流，而这正是经颅多普勒设备的主要用途。此外，领先的市场参与者在研发和产品开发方面不断投入，催生了先进、便携、整合人工智慧的经颅多普勒系统，使这项技术在各种临床环境中更易于获取和有效应用。这些因素共同推动了经颅多普勒市场的普及和成长，预计将在2025年至2032年的预测期内推动市场成长。

经颅多普勒市场动态：

根据国际脑损伤协会的数据，欧盟每年约有100万人因脑损伤住院。其中，机车事故占创伤性脑损伤(TBI)的50%。此外，运动相关的脑损伤也是造成这数字的重要原因，估计每年有30万人受伤。冬季运动，尤其是滑雪和冰上训练，与其中约2万人的脑损伤有关。日益加重的脑损伤负担推动了对先进即时诊断工具的需求。经颅多普勒超音波因其能够非侵入性地评估脑血流并检测血管併发症，越来越多地被用于创伤性脑损伤的急性和长期管理。这种日益增长的临床需求推动了经颅多普勒超音波市场的稳定成长。

根据世界卫生组织 (WHO) (2023) 的数据，到 2023 年，全球将有超过 180 万人患有多发性硬化症 (MS)。 MS 是一种影响大脑和脊髓功能的慢性免疫介导疾病。随着早期发现和监测血管问题变得至关重要，经颅多普勒超音波在非侵入性评估脑血流方面的重要性日益凸显。人们对 MS 的认识和诊断不断提高，推动了对先进神经诊断工具的需求，并促进了经颅多普勒超音波市场的发展。

此外，根据世界卫生组织 (WHO) (2024) 的数据，全球约有 5,000 万人患有癫痫，使其成为全球最常见的神经系统疾病之一。值得注意的是，近 80% 的癫痫患者生活在中低收入国家，这些国家获得适当诊断和治疗设施的机会仍然有限。据估计，透过准确的诊断和及时治疗，高达 70% 的癫痫患者可以实现无癫痫发作的生活。此外，全球每年报告约 500 万例新癫痫病例。这一沉重的疾病负担凸显了对便捷、非侵入性诊断工具日益增长的需求。经颅多普勒可以即时评估脑血流，并有助于识别与癫痫发作相关的血管异常。随着人们对癫痫的认识和医疗保健基础设施的不断提高，尤其是在医疗资源匮乏的地区，癫痫盛行率的上升预计将显着推动对经颅多普勒的需求。

因此，预计所有上述因素将在2025年至2032年的预测期内共同推动经颅多普勒市场的发展。

然而，严格的监管审批以及市场上替代方案的可用性等因素可能会抑制经颅多普勒市场的成长。

经颅多普勒市场细分分析：

经颅多普勒市场：产品类型（可携式、独立式、穿戴式）、操作模式（手动、自动）、最终用户（医院、门诊手术中心、其他）、地区（北美、欧洲、亚太地区、其他）

在经颅多普勒市场的操作模式细分中，自动化类别预计将在2024年占据最大的市场收入占有率。这项优势源自于自动化多普勒系统的优势，它能够提高诊断准确性、减少对操作员的依赖并简化临床工作流程。与手动系统不同，自动化经颅多普勒结合了人工智慧驱动的演算法和机器人辅助探头，能够以最少的使用者输入即时监测脑血流。这些系统提供标准化的数据解释，显着降低了由于操作员专业知识而导致的差异，并扩大了非专业人员和资源有限环境下的可及性。主要功能包括自动血管检测、即时波形分析以及基于云端的资料集成，可用于远端存取和远距医疗应用。

飞利浦的 D2tcd 探头提供自动化、非影像的 TCD 功能，并结合人工智慧技术，可识别血管并持续监测脑血流动力学。事实证明，此类技术创新在准确性和一致性至关重要的领域尤其有用，例如中风评估、创伤性脑损伤管理、神经重症监护和术中监测。远距医疗解决方案以及与医院资讯系统无缝整合的需求日益增长，进一步加速了自动化 TCD 系统的普及。

因此，预计自动化产业将在2025年至2032年期间经历显着成长，并对整个经颅多普勒市场的扩张做出重大贡献。

预计北美将主导整个经颅多普勒市场：

在所有地区中，预计北美将在2024年占据经颅多普勒市场的最大占有率。这可能是由于创伤性脑损伤发病率的上升、帕金森氏症患者的不断增长、产品开发和监管审批的重大进展，以及该地区主要市场参与者的存在。预计这些因素将推动经颅多普勒市场在2025年至2032年期间持续扩张和创新。

根据美国疾病管制与预防中心（2024年）的数据，美国每天有超过586例因创伤性脑损伤（TBI）住院治疗。 TBI通常由事故、跌倒、运动伤害等造成的头部创伤引起，需要快速且准确的诊断以评估脑损伤程度并确定治疗方案。此类损伤通常会导致骨折，需要手术介入和固定才能确保骨折完全癒合。损伤数量的增加推动了对快速、非侵入性诊断工具的需求，例如经颅多普勒超音波，它可以评估脑血流并确定脑损伤的严重程度。因此，TBI负担的加重已成为推动经颅多普勒市场成长的关键因素。

根据帕金森基金会 (2024) 的数据，到 2023 年，美国将有近 100 万人患有帕金森氏症，预计到 2030 年这一数字将增至 120 万。帕金森氏症是继阿兹海默症之后第二常见的神经退化性疾病，在老年人口中发病率持续上升，美国每年约有 9 万例新诊断病例。经颅多普勒超音波检查可以非侵入性地评估脑血流，越来越多地用于检测血管异常并监测神经退化性疾病患者的脑血流动态。因此，帕金森病患病率的上升极大地促进了经颅多普勒超音波检查市场的扩张。

此外，西门子医疗私人有限公司和佳能医疗系统公司等主要市场参与者的强大销售网络确保了这些设备在整个地区的广泛可用性和可及性，扩大了其市场收入占有率并在该地区站稳了脚跟，刺激了技术创新和市场增长。

因此，所有上述因素将在2025年至2032年的预测期内为经颅多普勒市场营造有利的环境。

经颅多普勒市场的主要公司

经颅多普勒市场的主要市场参与者包括Atys Medical、Compumedics Limited、NeuraSignal, Inc.、Recorders &Medicare Systems Pvt。 (RMS)、Rimed Ltd.、深圳德利卡医疗设备有限公司、Viasonix.、NeuraSignal, Inc.、柯尼卡美能达医疗印度私人有限公司、通用电气医疗集团、荷兰皇家飞利浦公司、迈瑞、富士胶片索诺声公司、西门子医疗私人有限公司和佳能医疗系统公司。

经颅多普勒市场的最新发展：

  • 2024年5月，加州大学圣地牙哥分校的工程师开发了一种穿戴式超音波贴片，用于非侵入性、持续监测脑血流。这款柔软、可拉伸的贴片设计用于佩戴在太阳穴上，可提供脑血流的三维数据。穿戴式超音波贴片代表了目前临床标准经颅多普勒超音波的重大飞跃。

经颅多普勒市场报告重点

  • 目前经颅多普勒市场规模分析（2024 年）及 8 年市场预测（2025-2032 年）
  • 过去三年主要产品/服务开发、合併、收购、合作及合资企业
  • 主导经颅多普勒市场的主要公司
  • 经颅多普勒市场中竞争对手面临的各种机会
  • 2024 年各细分市场的领先产业及其 2032 年的表现
  • 目前经颅多普勒市场中排名靠前的地区和国家
  • 未来经颅多普勒市场成长机会中企业应重点关注的地区和国家

关于经颅多普勒的常见问题多普勒市场

1. 经颅多普勒

  • 经颅多普勒是一种非侵入性超音波技术，用于测量主要脑动脉的血流速度。它提供即时血流动力学数据，可用于各种临床环境。

    2. 经颅多普勒市场

    • 预计在 2025 年至 2032 年的预测期内，经颅多普勒市场将以 5.89% 的复合年增长率成长。

    3.经颅多普勒市场驱动因子

    • 创伤性脑损伤 (TBI) 的增加、中风和脑血管痉挛等神经系统疾病的盛行率上升以及运动相关损伤的急剧增加，极大地推动了全球对经颅多普勒设备的需求。这些情况需要持续、即时监测脑血流，而这正是经颅多普勒设备的主要应用。此外，市场领先的公司正在大力投资研发和产品开发，从而推动了先进、便携且整合人工智慧的经颅多普勒设备的开发。经颅多普勒系统的推出使得这项技术在各种临床环境中更加普及且更有效。这些因素共同推动了经颅多普勒市场的普及和成长，并预计在2025年至2032年的预测期内推动市场发展。

    4.开展经颅都卜勒超音波市场上事业的主要企业有哪些？

    • 进入到经颅都卜勒超音波市场的主要打入市场企业有Compumedics Limited，NeuraSignal, Inc.，Recorders &Medicare Systems Pvt Ltd(RMS)，Rimed Ltd.，深圳 Delica Medical Equipment Co，Viasonix，NeuraSignal, Inc.，Konica Minolta Healthcare India Private Limited，GE HealthCare，Koninklijke Philips N.V.，Mindray，FUJIFILM Sonosite, Inc.，Siemens Healthcare Private Limited，CANON MEDICAL SYSTEMS 有CORPORATION等。

    5. 经颅多普勒市占率最大的地区

    • 在所有地区中，预计北美将在2024年占据经颅多普勒市场的最大收入占有率。这可能是由于创伤性脑损伤盛行率的上升、帕金森氏症患者的成长、产品开发和监管审批的显着进展，以及该地区主要市场参与者的重大贡献。预计这些综合因素将在2025年至2032年期间推动经颅多普勒市场持续扩张和创新。

    目录

    第1章 经颅都卜勒超音波市场报告的简介

    第2章 经颅都卜勒超音波市场摘要整理

    第3章 竞争情形

    第4章 法规分析

    • 美国
    • 欧洲
    • 日本
    • 中国

    第5章 经颅都卜勒超音波市场主要原因分析

    • 经颅多普勒市场推动因素
      • 脑外伤发生率上升损伤
      • 神经系统疾病盛行率不断上升
      • 运动相关伤害不断增加
    • 经颅多普勒市场的限制与挑战
      • 严格的监管审批
      • 市场上替代方案的可用性
    • 经颅多普勒市场机遇
      • 经颅多普勒监测设备中人工智慧 (AI) 与云端平台的集成

    第6章 经颅都卜勒超音波市场波特的五力分析

    第7章 经颅都卜勒超音波市场评估

    • 各产品类型
      • 可携式
      • 独立的
      • 穿戴式
    • 行动模式别
      • 手动
      • 自动
    • 各终端用户
      • 医院
      • 门诊病人手术中心
      • 其他
    • 地区
      • 北美
      • 欧洲
      • 亚太地区
      • 其他地区

    第8章 经颅都卜勒超音波市场企业与产品简介

    • Atys Medical
    • Compumedics Limited
    • NeuraSignal, Inc.
    • Recorders & Medicare Systems Pvt Ltd (RMS)
    • Rimed Ltd.
    • Shenzhen Delica Medical Equipment Co., Ltd.
    • Viasonix.
    • NeuraSignal, Inc.
    • Konica Minolta Healthcare India Private Limited
    • GE HealthCare
    • Koninklijke Philips N.V.
    • Mindray
    • FUJIFILM Sonosite, Inc.
    • Siemens Healthcare Private Limited
    • CANON MEDICAL SYSTEMS CORPORATION

    第9章 KOL的见解

    第10章 计划方法

    第11章 关于DelveInsight

    第12章 免责声明和咨询方式

Product Code: DIMDCL0245

Transcranial Doppler Market by Product Type (Portable, Stand-alone, and Wearable), Mode of Operation (Manual and Automated), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2032 owing to the increasing incidence of traumatic brain injuries, rising prevalence of neurological disorders, and increasing sport related injuries.

The transcranial doppler market is estimated to grow at a CAGR of 5.89% during the forecast period from 2025 to 2032. The increasing instances of traumatic brain injuries (TBI), rising prevalence of neurological disorders such as stroke and cerebral vasospasm, and the surge in sport-related injuries are significantly boosting the demand for transcranial doppler devices globally. These conditions require continuous and real-time monitoring of cerebral blood flow, a key application of transcranial doppler devices. Additionally, growing investments in R&D and product development by key market players have led to the launch of advanced, portable, and AI-integrated transcranial doppler devices systems, making the technology more accessible and effective across diverse clinical settings. Collectively, these factors are driving the widespread adoption and growth of the transcranial doppler market, that are expected to drive the transcranial doppler market during the forecast period from 2025 to 2032.

Transcranial Doppler Market Dynamics:

According to the International Brain Injury Association (2025), brain injuries resulted in approximately one million hospital admissions annually within the European Union. Among these, motor vehicle crashes were responsible for 50% of traumatic brain injuries (TBIs). Additionally, sports-related brain injuries contributed significantly to this figure, with an estimated 300,000 injuries occurring each year. Winter sports, particularly skiing and ice-skating, were linked to around 20,000 of these brain injuries. The growing burden of brain injuries is driving demand for advanced, real-time diagnostic tools. Transcranial Doppler, with its ability to non-invasively assess cerebral blood flow and detect vascular complications, is increasingly being adopted in the acute and long-term management of traumatic brain injuries. This rising clinical need is contributing to the steady growth of the transcranial doppler market.

According to the World Health Organization (2023), over 1.8 million people worldwide were living with multiple sclerosis (MS) in 2023. Multiple sclerosis (MS) is a chronic, immune-mediated disorder affecting brain and spinal cord functions. As early detection and monitoring of vascular issues become essential, transcranial Doppler ultrasound is gaining importance for its non-invasive assessment of cerebral blood flow. Growing awareness and diagnosis of MS are driving demand for advanced neurodiagnostic tools, boosting the transcranial doppler market.

Moreover, according to the World Health Organization (2024), approximately 50 million people worldwide were living with epilepsy, making it one of the most prevalent neurological disorders globally. Notably, nearly 80% of individuals with epilepsy reside in low- and middle-income countries, where access to proper diagnostic and treatment facilities remains limited. It was estimated that up to 70% of people with epilepsy could achieve seizure-free lives with accurate diagnosis and timely treatment. Furthermore, around 5 million new cases of epilepsy are reported globally each year. This substantial disease burden highlights the growing need for accessible, non-invasive diagnostic tools. Transcranial doppler, which enables real-time assessment of cerebral blood flow and can aid in identifying vascular abnormalities associated with seizure activity, is emerging as a valuable tool in both diagnosis and monitoring. As awareness and healthcare infrastructure improve, especially in underserved regions, the increasing prevalence of epilepsy is expected to significantly drive demand for transcranial doppler.

Hence, the interplay of all the above-mentioned factors is expected to drive the market of transcranial doppler market during the given forecast period from 2025 to 2032.

However, the stringent regulatory approvals and availability of alternative options in the market, among others, may restrain the growth of the transcranial doppler market.

Transcranial Doppler Market Segment Analysis:

Transcranial Doppler Market by Product Type (Portable, Stand-alone, and Wearable), Mode of Operation (Manual and Automated), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the mode of operation segment of the transcranial doppler market, the automated category is projected to hold the largest share of market revenue in 2024. This dominance is driven by the advantages of automated doppler systems, which enhance diagnostic accuracy, reduce operator dependency, and streamline clinical workflows. Unlike manual systems, automated transcranial dopplers incorporate AI-driven algorithms and robotic-assisted probes to enable real-time monitoring of cerebral blood flow with minimal user input. These systems deliver standardized data interpretation, significantly reducing variability due to operator expertise and expanding accessibility in non-specialist and resource-limited settings. Key features include automated vessel detection, real-time waveform analysis, and cloud-based data integration for remote access and telemedicine applications.

One notable example is the Philips D2tcd transducer, which offers automated, non-imaging TCD capabilities with AI support for vessel identification and continuous cerebral hemodynamic monitoring. Such innovations are proving especially valuable in stroke assessment, traumatic brain injury management, neurocritical care, and intraoperative monitoring, areas where accuracy and consistency are critical. The increasing demand for telehealth-compatible solutions and seamless integration with hospital information systems has further accelerated the adoption of automated TCD systems.

As a result, the automated segment is expected to experience significant growth, substantially contributing to the overall expansion of the transcranial doppler market from 2025 to 2032.

North America is expected to dominate the overall transcranial doppler market:

Among all the regions, North America is expected to amass the largest share of the transcranial doppler market in 2024. This can be ascribed to the rising incidence of traumatic brain injuries, growing population with Parkinson's disease, significant advancements in product development & regulatory approvals, and the presence of key market players in the region. The combination of these factors is expected to drive the continued expansion and innovation in the transcranial doppler market from 2025 to 2032.

According to data from the Centers for Disease Control and Prevention (2024), the United States experiences over 586 traumatic brain injury (TBI)-related hospitalizations each day. TBIs, often resulting from head trauma due to accidents, falls, or sports injuries, require prompt and accurate diagnosis to assess the extent of brain damage and inform treatment decisions. These injuries frequently lead to fractures that necessitate surgical intervention and stabilization to ensure proper healing. The growing instances of such trauma have heightened the need for rapid, non-invasive diagnostic tools such as transcranial doppler ultrasound, which can evaluate cerebral blood flow and determine the severity of brain injury. As a result, the increasing burden of TBIs is emerging as a major factor driving the growth of the transcranial doppler market.

According to the Parkinson's Foundation (2024), nearly one million individuals in the United States were living with Parkinson's disease in 2023, with the number projected to rise to 1.2 million by 2030. As the second-most common neurodegenerative disorder after Alzheimer's disease, Parkinson's continues to affect a growing segment of the aging population, with approximately 90,000 new cases diagnosed annually in the U.S. This rising prevalence underscores the urgent need for effective diagnostic and monitoring tools. Transcranial doppler, which enables non-invasive assessment of cerebral blood flow, is increasingly being utilized to detect vascular abnormalities and monitor cerebral hemodynamics in patients with neurodegenerative conditions. As a result, the growing incidence of parkinson's disease is contributing significantly to the expansion of the transcranial doppler market.

Moreover, the presence of key market players such as Siemens Healthcare Private Limited and CANON MEDICAL SYSTEMS CORPORATION, with their strong distribution networks, ensures widespread availability and accessibility of these devices across the region, increasing their revenue shares in the market have establishing strong footholds in the region, driving innovation and market growth.

Thus, all the factors mentioned above promote a conducive environment for the transcranial doppler market during the forecast period from 2025 to 2032.

Transcranial Doppler Market Key Players:

Some of the key market players operating in the transcranial doppler market include Atys Medical, Compumedics Limited, NeuraSignal, Inc., Recorders & Medicare Systems Pvt Ltd. (RMS), Rimed Ltd., Shenzhen Delica Medical Equipment Co., Ltd., Viasonix., NeuraSignal, Inc., Konica Minolta Healthcare India Private Limited, GE HealthCare, Koninklijke Philips N.V., Mindray, FUJIFILM Sonosite, Inc., Siemens Healthcare Private Limited, CANON MEDICAL SYSTEMS CORPORATION, and others.

Recent Developmental Activities in the Transcranial Doppler Market:

  • In May 2024, Engineers at the University of California, San Diego developed a wearable ultrasound patch capable of providing continuous, non-invasive monitoring of blood flow in the brain. The soft and stretchy patch was designed to be worn on the temple, offering three-dimensional data on cerebral blood flow, marking a first in wearable technology. The wearable ultrasound patch marks a significant leap from the current clinical standard, called transcranial Doppler ultrasound.

Key takeaways from the transcranial doppler market report study

  • Market size analysis for current transcranial doppler market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the transcranial doppler market
  • Various opportunities available for the other competitors in the transcranial doppler market space
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current transcranial doppler market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for transcranial doppler market growth in the coming future?

Target audience who can benefit from this transcranial doppler market report study

  • Transcranial Doppler providers
  • Research organizations and consulting companies
  • Transcranial doppler related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in transcranial doppler
  • Various end-users who want to know more about the transcranial doppler market and the latest developments in the transcranial doppler market

Frequently Asked Questions for the Transcranial Doppler Market:

1. What are transcranial doppler?

  • The transcranial doppler is a non-invasive ultrasound technique used to measure blood flow velocity in the major cerebral arteries. It provides real-time data on hemodynamics, making it valuable in various clinical settings.

2. What is the market for transcranial doppler?

  • The transcranial doppler market is estimated to grow at a CAGR of 5.89% during the forecast period from 2025 to 2032.

3. What are the drivers for the transcranial doppler market?

  • The increasing instances of traumatic brain injuries (TBI), rising prevalence of neurological disorders such as stroke and cerebral vasospasm, and the surge in sport-related injuries are significantly boosting the demand for transcranial doppler devices globally. These conditions require continuous and real-time monitoring of cerebral blood flow, a key application of transcranial doppler devices. Additionally, growing investments in R&D and product development by key market players have led to the launch of advanced, portable, and AI-integrated transcranial doppler systems, making the technology more accessible and effective across diverse clinical settings. Collectively, these factors are driving the widespread adoption and growth of the transcranial doppler market, that are expected to drive the transcranial doppler market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the transcranial doppler market?

  • Some of the key market players operating in the transcranial doppler market include Compumedics Limited, NeuraSignal, Inc., Recorders & Medicare Systems Pvt Ltd (RMS), Rimed Ltd., Shenzhen Delica Medical Equipment Co., Ltd., Viasonix, NeuraSignal, Inc., Konica Minolta Healthcare India Private Limited, GE HealthCare, Koninklijke Philips N.V., Mindray, FUJIFILM Sonosite, Inc., Siemens Healthcare Private Limited, CANON MEDICAL SYSTEMS CORPORATION, and others.

5. Which region has the highest share in the transcranial doppler market?

  • Among all the regions, North America is estimated to hold a significant revenue share in the transcranial doppler market in 2024. This can be ascribed to the rising incidence of traumatic brain injuries, growing population with parkinson's disease, significant advancements in product development & regulatory approvals, and the significant contributions of key market players in the region. The combination of these factors is expected to drive the continued expansion and innovation in the transcranial doppler market from 2025 to 2032.

Table of Contents

1. Transcranial Doppler Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Transcranial Doppler Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Transcranial Doppler Market Key Factors Analysis

  • 5.1. Transcranial Doppler Market Drivers
    • 5.1.1. Increasing incidence of traumatic brain injuries
    • 5.1.2. Rising prevalence of neurological disorders
    • 5.1.3. A growing number of sports-related injuries
  • 5.2. Transcranial Doppler Market Restraints and Challenges
    • 5.2.1. Stringent regulatory approvals
    • 5.2.2. Availability of alternative options in the market
  • 5.3. Transcranial Doppler Market Opportunities
    • 5.3.1. Integration with Artificial Intelligence (AI) and cloud platforms in transcranial doppler monitoring devices

6. Transcranial Doppler Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Transcranial Doppler Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Portable
    • 7.1.2. Stand-alone
    • 7.1.3. Wearable
  • 7.2. By Mode of Operation
    • 7.2.1. Manual
    • 7.2.2. Automated
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.1.2. Canada Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.1.3. Mexico Transcranial Doppler Market Size in USD million (2022-2032)
    • 7.4.2. Europe
      • 7.4.2.1. France Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.2.2. Germany Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.2.3. United Kingdom Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.2.4. Italy Transcranial Doppler market size in USD million (2022-2032)
      • 7.4.2.5. Spain Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.2.6. Rest of Europe Transcranial Doppler Market Size in USD million (2022-2032)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.3.2. Japan Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.3.3. India Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.3.4. Australia Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.3.5. South Korea Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.3.6. Rest of Asia-Pacific Transcranial Doppler Market Size in USD million (2022-2032)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.4.2. Africa Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.4.3. South America Transcranial Doppler Market Size in USD million (2022-2032)

8. Transcranial Doppler Market Company and Product Profiles

  • 8.1. Atys Medical
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Compumedics Limited
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. NeuraSignal, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Recorders & Medicare Systems Pvt Ltd (RMS)
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Rimed Ltd.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Shenzhen Delica Medical Equipment Co., Ltd.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Viasonix.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. NeuraSignal, Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Konica Minolta Healthcare India Private Limited
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. GE HealthCare
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Koninklijke Philips N.V.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Mindray
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. FUJIFILM Sonosite, Inc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Siemens Healthcare Private Limited
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. CANON MEDICAL SYSTEMS CORPORATION
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Transcranial Doppler Market in Global (2022-2032)
  • Table 3: Transcranial Doppler Market in Global by Product Type (2022-2032)
  • Table 4: Transcranial Doppler Market in Global by Mode of Operation (2022-2032)
  • Table 5: Transcranial Doppler Market in Global by End-User (2022-2032)
  • Table 6: Transcranial Doppler Market in Global by Geography (2022-2032)
  • Table 7: Transcranial Doppler Market in North America (2022-2032)
  • Table 8: Transcranial Doppler Market in the United States (2022-2032)
  • Table 9: Transcranial Doppler Market in Canada (2022-2032)
  • Table 10: Transcranial Doppler Market in Mexico (2022-2032)
  • Table 11: Transcranial Doppler Market in Europe (2022-2032)
  • Table 12: Transcranial Doppler Market in France (2022-2032)
  • Table 13: Transcranial Doppler Market in Germany (2022-2032)
  • Table 14: Transcranial Doppler Market in United Kingdom (2022-2032)
  • Table 15: Transcranial Doppler Market in Italy (2022-2032)
  • Table 16: Transcranial Doppler Market in Spain (2022-2032)
  • Table 17: Transcranial Doppler Market in Rest of Europe (2022-2032)
  • Table 18: Transcranial Doppler Market in Asia-Pacific (2022-2032)
  • Table 19: Transcranial Doppler Market in China (2022-2032)
  • Table 20: Transcranial Doppler Market in Japan (2022-2032)
  • Table 21: Transcranial Doppler Market in India (2022-2032)
  • Table 22: Transcranial Doppler Market in Australia (2022-2032)
  • Table 23: Transcranial Doppler Market in South Korea (2022-2032)
  • Table 24: Transcranial Doppler Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Transcranial Doppler Market in Rest of the World (2022-2032)
  • Table 26: Transcranial Doppler Market in the Middle East (2022-2032)
  • Table 27: Transcranial Doppler Market in Africa (2022-2032)
  • Table 28: Transcranial Doppler Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Transcranial Doppler Market in Global (2022-2032)
  • Figure 3: Transcranial Doppler Market in Global by Product Type (2022-2032)
  • Figure 4: Transcranial Doppler Market in Global by Mode of Operation (2022-2032)
  • Figure 5: Transcranial Doppler Market in Global by End-User (2022-2032)
  • Figure 6: Transcranial Doppler Market in Global by Geography (2022-2032)
  • Figure 7: Transcranial Doppler Market in North America (2022-2032)
  • Figure 8: Transcranial Doppler Market in the United States (2022-2032)
  • Figure 9: Transcranial Doppler Market in Canada (2022-2032)
  • Figure 10: Transcranial Doppler Market in Mexico (2022-2032)
  • Figure 11: Transcranial Doppler Market in Europe (2022-2032)
  • Figure 12: Transcranial Doppler Market in France (2022-2032)
  • Figure 13: Transcranial Doppler Market in Germany (2022-2032)
  • Figure 14: Transcranial Doppler Market in United Kingdom (2022-2032)
  • Figure 15: Transcranial Doppler Market in Italy (2022-2032)
  • Figure 16: Transcranial Doppler Market in Spain (2022-2032)
  • Figure 17: Transcranial Doppler Market in Rest of Europe (2022-2032)
  • Figure 18: Transcranial Doppler Market in Asia-Pacific (2022-2032)
  • Figure 19: Transcranial Doppler Market in China (2022-2032)
  • Figure 20: Transcranial Doppler Market in Japan (2022-2032)
  • Figure 21: Transcranial Doppler Market in India (2022-2032)
  • Figure 22: Transcranial Doppler Market in Australia (2022-2032)
  • Figure 23: Transcranial Doppler Market in South Korea (2022-2032)
  • Figure 24: Transcranial Doppler Market in Rest of Asia-Pacific (2022-2032)
  • Figure 25: Transcranial Doppler Market in Rest of the World (2022-2032)
  • Figure 26: Transcranial Doppler Market in the Middle East (2022-2032)
  • Figure 27: Transcranial Doppler Market in Africa (2022-2032)
  • Figure 28: Transcranial Doppler Market in South America (2022-2032)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis